apomorphine has been researched along with Bradykinesia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Kadiri, SK; Karkar, VV; Pal Roy, S; Rao Konijeti, S | 1 |
| Abuleil, A; Ajagbe, AO; Alhendawi, BHM; Badri, R; Chaaya, C; Chalhoub, E; Korkusuz, AK; Onyeaka, H; Uwishema, O; Yücel, AN | 1 |
| Barbiani, D; Benedetti, F; Carlino, E; Dematteis, F; Frisaldi, E; Lanotte, M; Lopiano, L; Zibetti, M | 1 |
| Avcı, B; Balcı, H; Bilge, SS; Bozkurt, A; Günaydın, C; Önger, ME | 1 |
| Anan, C; Bhidayasiri, R; Boonpang, K; Ray Chaudhuri, K; Sringean, J; Thanawattano, C | 1 |
| Dewhurst, F; Lee, M; Wood, B | 1 |
| Byers, DM; Del Val, S; Irwin, LN; Moss, DE; Sumaya, IC | 1 |
| Costentin, J; Marçais, H; Protais, P; Schwartz, JC | 1 |
| Eggert, K; Möller, JC; Oertel, WH; Sommer, N; Tackenberg, B | 1 |
| Asmus, F; Bötzel, K; Deutschländer, A; Gasser, T; Klopstock, T; Marelli, E | 1 |
| Poewe, W; Schelosky, L; Scholz, U; Schrag, A | 1 |
1 trial(s) available for apomorphine and Bradykinesia
| Article | Year |
|---|---|
Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Apomorphine; Biperiden; Cholinergic Antagonists; Cross-Over Studies; Dopamine Agonists; Female; Humans; Hypokinesia; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Single-Blind Method; Tremor | 1999 |
10 other study(ies) available for apomorphine and Bradykinesia
| Article | Year |
|---|---|
Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adjuvants, Immunologic; Animals; Antioxidants; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Brain; Catalepsy; Catatonia; Dopamine; Haloperidol; Hypokinesia; Muscle Rigidity; Plant Bark; Rats; Reserpine; Tabebuia; Tremor; Water | 2022 |
The understanding of Parkinson's disease through genetics and new therapies.
Topics: alpha-Synuclein; Apomorphine; Dopaminergic Neurons; Humans; Hypokinesia; Parkinson Disease; Tremor | 2022 |
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning.
Topics: Aged; Apomorphine; Dopamine Agents; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Placebo Effect | 2017 |
Effects of agomelatine in rotenone-induced Parkinson's disease in rats.
Topics: Acetamides; Animals; Apomorphine; Apoptosis; Brain; Cell Count; Corpus Striatum; Hypokinesia; Male; Neurons; Oxidation-Reduction; Parkinsonian Disorders; Proteins; Rats; Rotarod Performance Test; Rotation; Rotenone | 2019 |
Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors.
Topics: Aged; Apomorphine; Circadian Rhythm; Dopamine Agonists; Female; Humans; Hypokinesia; Infusions, Subcutaneous; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Wearable Electronic Devices | 2016 |
The pragmatic use of apomorphine at the end of life.
Topics: Aged; Antiemetics; Antiparkinson Agents; Apomorphine; Blinking; Deglutition Disorders; Domperidone; Humans; Hypokinesia; Male; Nausea; Parkinson Disease; Terminal Care | 2009 |
Circadian-dependent effect of melatonin on dopaminergic D2 antagonist-induced hypokinesia and agonist-induced stereotypies in rats.
Topics: Animals; Apomorphine; Circadian Rhythm; Darkness; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Fluphenazine; Hypokinesia; Light; Male; Melatonin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior | 2004 |
Tolerance to hypokinesia elicited by dopamine agonists in mice: hyposensitization of autoreceptors?
Topics: Amphetamine; Animals; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Hypokinesia; Male; Mice; Motor Activity; Piribedil; Receptors, Dopamine | 1977 |
Akinetic crisis caused by rectus sheath hematoma and acute anemia due to subcutaneous administration of apomorphine.
Topics: Acute Disease; Aged; Anemia; Antiparkinson Agents; Apomorphine; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Hematoma; Humans; Hypokinesia; Infusions, Parenteral; Leukocytosis; Male; Parkinson Disease; Pneumonia, Pneumococcal; Radiography; Rectus Abdominis | 2006 |
Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
Topics: Administration, Oral; Amantadine; Antiparkinson Agents; Apomorphine; Combined Modality Therapy; Deep Brain Stimulation; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Hypokinesia; Infusions, Intravenous; Injections, Subcutaneous; Levodopa; Middle Aged; Neurologic Examination; Optic Atrophy; Parkinson Disease | 2006 |